Ming Ming Lee

About

Ming Ming Lee is a pioneering urologic surgeon and researcher whose work has fundamentally advanced the surgical management of bladder cancer, particularly through the adoption and refinement of robotic-assisted radical cystectomy (RRC). Lee’s primary research focus lies in optimizing surgical outcomes for bladder urothelial carcinoma, with a specific emphasis on understanding and mitigating postoperative complications. In a landmark 2009 study (102 citations), Lee provided the first critical, standardized analysis of complications following RRC, identifying key preoperative and operative risk factors—a contribution that has since guided surgical decision-making and improved patient safety protocols worldwide. Building on this, Lee’s 2010 investigation (58 citations) established early oncological outcomes and survival rates for RRC patients, offering crucial evidence that robotic techniques could achieve oncologic efficacy comparable to open surgery while potentially reducing morbidity. Through these seminal works, Lee has not only shaped best practices in minimally invasive urologic oncology but also provided a rigorous framework for evaluating new surgical technologies. Lee’s research continues to influence how surgeons approach high-risk procedures, making him a leading voice in the evolution of robotic urologic surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Critical analysis of complications after robotic‐assisted radical cystectomy with identification of preoperative and operative risk factors

   102 citations · 2009
2. 2
   Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic‐assisted radical cystectomy

   58 citations · 2010

Key Collaborators

Contact & Links